In this work we utilise different electrical and optical mapping technologies to identify and explore possible mechanisms that could underlie conduction heterogeneity in the RyR2-R420Q preclinical model of CPVT. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.